{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih3tjb47tpacsq7buo6tut3aftirgg725yxahaubzj4rcozmxmx64",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mel3rthrxuh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaolckgkapcqjgkojrxqxkarvalsx4emnmklewl7mokpfkinzozo4"
    },
    "mimeType": "image/jpeg",
    "size": 84502
  },
  "path": "/2026/02/10/biotech-news-nektar-and-evommune-eczema-study-results/?utm_campaign=rss",
  "publishedAt": "2026-02-10T14:55:19.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "And other biotech news brought to you by The Readout",
  "title": "STAT+: Evommune reports positive mid-stage data for eczema drug",
  "updatedAt": "2026-02-10T14:55:23.000Z"
}